Abstract: Fungal infections pose a significant global health burden, affecting millions annually, particularly in resource-limited regions. Traditional antifungal therapies, while effective, often present challenges such as limited skin penetration, systemic toxicity, and undesirable side effects, necessitating frequent application of high drug doses. Nanogel formulations offer a promising solution by integrating advanced nanotechnology with enhanced drug delivery systems. These innovative formulations combine the benefits of nanocarriers and hydrogel matrices, ensuring improved drug stability, controlled release, and targeted delivery to infection sites. Nanogels enhance therapeutic efficacy by facilitating deeper penetration into skin layers and maintaining localized drug concentration, thereby minimizing systemic exposure and associated toxicities. They are versatile in encapsulating both hydrophilic and hydrophobic antifungal agents, addressing a wide spectrum of fungal infections, from superficial conditions like tinea versicolor to invasive subcutaneous mycoses. Additionally, the non-greasy, lightweight texture and reduced risk of irritation improve patient compliance, which is crucial for effective treatment outcomes. Recent advancements in nanogel technology include the incorporation of natural oils, combination therapies, and stimuli-responsive systems, further broadening their therapeutic potential. Research into optimizing particle size, zeta potential, and formulation stability continues to enhance their clinical applicability. Moreover, nanogels show promise in overcoming antifungal resistance and exploring applications for systemic and neurological fungal infections. In conclusion, nanogel formulations offer a safer, more effective, and patient-friendly alternative to traditional antifungal treatments. With continued innovation and standardization, they hold the potential to significantly reduce the global burden of fungal diseases and revolutionize dermatological therapy.
Pandey et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: